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Abstract
Background: Hepatitis delta virus (HDV) is considered to be a satellite virus of the Hepatitis B virus. The genome
consists of a 1679 nt ssRNA molecule in which a single ORF was identified. This ORF codes for a unique protein,
the Delta antigen (HDAg). During transcription, two forms, small (S-HDAg; p24) and large (L-HDAg; p27) of this
antigen are derived as a result of an editing mechanism catalyzed by cellular adenosine deaminase 1. Despite its
simplicity, little is still known about the host factors that interact with the virus RNA and antigens being to
modulate virus replication.
Methods: A yeast two-hybrid screening of a human liver cDNA library, using the hepatitis delta virus (HDV) small
antigen (S-HDAg) as bait, was performed. Blot overlay and co-immunoprecipitation assays were used in an attempt
to confirm the interaction of hnRNPC and S-HDAg. siRNA knockdown assays of hnRNPC were performed to assess
the effect on HDV antigen expression.
Results: Thirty known proteins were identified as S-HDAg interactors in the yeast two-hybrid screening. One of the
identified proteins, hnRNPC, was found to interact with S-HDAg in vitro and in vivo in human liver cells. The
interaction of the two proteins is mediated by the C-terminal half of the S-HDAg which contains a RNA-binding
domain (aa 98-195). HDV RNA, S-HDAg, and hnRNPC, were also found to co-localize in the nucleus of human liver
cells. Knockdown of hnRNPC mRNA using siRNAs resulted in a marked decreased expression of HDV antigens.
Conclusions: S-HDAg was found to interact with human liver proteins previously assigned to different functional
categories. Among those involved in nucleic acid metabolism, hnRNPC was found to interact in vitro and in vivo in
human liver cells. Similar to other RNA viruses, it seems plausible that hnRNPC may also be involved in HDV
replication. However, further investigation is mandatory to clarify this question.
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Background
Hepatitis delta virus (HDV) is a satellite virus of the
hepatitis B virus (HBV) and the only member of the
Deltagenus. The association between the two viruses is
due to the fact that the HDV envelope consists of HBV
surface antigens (HBsAg) which are necessary for virus
propagation [1,2]. The HDV genome consists of a 1.7
Kb, circular, ssRNA molecule of negative polarity in
which a single ORF was identified (reviewed in [3]).
Transcription from this ORF results in the production
of a 0.8 kb mRNA molecule that codes for a 195 ami-
noacid protein, the small delta antigen (S-HDAg). Dur-
ing transcription, an editing mechanism catalyzed by
cellular adenosine deaminase (ADAR 1) converts an
amber stop codon UAG to a tryptophan codon UGG
extending this ORF by an additional 19 aminoacids
resulting in the production of the large delta antigen (L-
HDAg) [4]. It is generally accepted that replication of
the genome occurs via a rolling-circle mechanism that
involves the participation of host RNA polymerase II
[5]. As a consequence, multimeric antigenomic
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cleaved and ligated at precise monomeric intervals. The
newly produced antigenomes serve as templates for the
synthesis of genomic RNA by a similar mechanism. Sev-
eral functions have been assigned to both forms of the
delta antigen and it is consensual that S-HDAg is neces-
sary for RNA accumulation [6], and L-HDAg interacts
with HBsAgs playing an important role during virus
packaging [7]. However, the host factors that participate
in the different steps of the HDV replication cycle inter-
acting with both RNA and antigens are largely
unknown. Recently, Cao et al reported the use of an
immunoprecipitation approach followed by mass spec-
trometry to identify S-HDAg interactors [8]. Over 100
proteins were identified including nine RNA polymerase
II subunits, transcription and splicing factors, RNA heli-
cases, and hnRNPs.
hnRNPs are abundant nuclear proteins that belong to
the large family of RNA-binding proteins containing
highly conserved amino acid sequences among verte-
brates [9]. These proteins associate with primary tran-
scripts of RNA polymerase II to form hnRNP nuclear
complexes. These complexes assist mRNA processing,
including the stabilization of pre-mRNAs for nuclear
export and translation [10,11]. The most abundant pro-
tein in hnRNP nuclear complexes is hnRNPC. Two iso-
forms of hnRNPC (C1 and C2) are produced by
alternative splicing and hnRNPC2 was found to contain
13 additional amino acids being expressed at about one-
third the level of hnRNPC1 [12]. The two isoforms form
stable heterotetramers [(C1)3C2] that bind cooperatively
to RNA [13].
It has been previously reported that several viruses
interact with members of the hnRNP family. In particu-
lar, hnRNPs were shown to play important roles during
replication of hepatitis C virus (HCV) [14,15], Sindbis
virus [16], and vesicular stomatitis virus (VSV) [17].
Recently, hnRNPC was suggested to influence the viral
replication of dengue virus by favoring survival in the
host [18].
In an attempt to identify cellular factors that interact
w i t ht h eS - H D A gw eu s e day e a s tt w o - h y b r i ds y s t e mt o
screen a human liver cDNA library. We were able to
identify 30 known proteins, including hnRNPC. This
protein was found to be expressed in 5 positive clones
initially obtained and was also observed in the above
mentioned study by Cao et al. [8] to interact with
FLAG-S-HDAg. Here, we report that hnRNPC and S-
HDAg interact in vitro and in vivo,a n dc o - l o c a l i z ei n
human liver cells. Using plasmid constructs coding for
different aminoacid sequences, in yeast two-hybrid
assays, we could observe that the two proteins interact
through their respective RNA binding domains. Finally,
knockdown of hnRNPC in cells undergoing HDV repli-
cation, leads to a decrease in both S-HDAg and L-
HDAg protein expression. Taken together, our data sug-
gest that the S-HDAg/hnRNPC interaction here
reported is specific and may be important for modula-
tion of HDV replication.
Methods
Construction of plasmids
For yeast two-hybrid assays, recombinant expression
plasmids were constructed using pAS2-1 (BD Bios-
ciences). In this vector, the inserted genes are expressed
in-frame with a GAL4 DNA-binding domain (GAL4BD).
To construct plasmid pAS2-1/S-HDAg, the gene cod-
ing for the S-HDAg was amplified by PCR using plasmid
pSVL-AgS [19] as template and specific primers (Table
1). After digestion with MunIa n dSalI, the resulting
fragment was cloned into the pAS2-1 EcoRI/SalIs i t e s .
Three S-HDAg deletion mutants were also cloned in
vector pAS2-1. The deletion mutants, encoding S-HDAg
amino acids 1-62, 63-97 or 98-195 were generated by
PCR amplification, using pSVL-AgS as template and the
primers listed in Table 1. These plasmids were named
pAS2-1/S-HDAg (1-62), pAS2-1/S-HDAg (63-97) and
pAS2-1/S-HDAg (98-195).
For the production of recombinant proteins, the bac-
terial expression vectors pGEX-6P-2 (GE Healthcare)
and pET28c (Novagen) were used to produce GST or
His-tagged fusion proteins, respectively. To construct
pGEX-6P-2/S-HDAg, for expression of GST/S-HDAg,
the S-HDAg cDNA was obtained by digestion of
pEGFP-C1-HDAg [20] with BglII and SalI, and then
inserted into the XhoI/BamHI cloning sites of pGEX-
Table 1 Oligonucleotides used to generate specific S-HDAg cDNA fragments by PCR
Plasmid name Oligonucleotide sequence (5’ ®3’)
Fwd Rev
pAS2-1/S-HDAg TTATCAATTGATGAGCCGGTCCGAGTCG TTATGTCGACCTATGGAAATCCCTGGTTTCCC
pAS2-1/S-HDAg
(1-62)
TTATCAATTGATGAGCCGGTCCGAGTCG TTATGTCGACCCATCCTTATCCTTCTTTCCGAG
pAS2-1/S-HDAg (63-97) TTATCAATTGCTGGATAAGGATGGAGAGGGG TTATGTCGACGTCGGTGAATCCTCCCCTG
pAS2-1/S-HDAg (98-165) TTATCAATTGAAGGAGAGGCAGGATCACCG TTATGTCGACCTATGGAAATCCCTGGTTTCCC
pET28c/hnRNPC TTATCAATTGGGATGGCCAGCAACGTTACC TTATGTCGACGTGCTTAAGAGTCATCCTCGCC
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pET28c/hnRNPC, was constructed by amplifying the
hnRNPC cDNA in pOTB7 (Image clone # 3354131)
using the primers pET28c/hnRNPC listed in Table 1.
The resulting fragment was cleaved with MunI and SalI,
and cloned into pET28c, in the EcoRI/SalI sites.
Yeast two-hybrid assay
The Matchmaker GAL4 Two-hybrid system (BD Bios-
ciences) was used to screen for proteins that interact
with S-HDAg from a human liver cDNA library (BD
Biosciences). Yeast two hybrid screening was performed
using materials and protocols provided by the manufac-
turer. Briefly, Saccharomyces cerevisiae AH109 strain
pre-transformed with bait plasmid pAS2-1/S-HDAg
were mated with an Y187 strain pre-transformed with a
liver cDNA library expressing fusions of GAL4 activa-
tion domain. The mating mixture was plated on syn-
thetic medium lacking tryptophan, leucine, histidine and
adenine and then assayed for a-galactosidade activity
(SD/-Trp/-Leu/-Hist/-Ade/X-a-gal medium).
Plasmids isolated from positive colonies were used to
transform E. coli DH5a cells and then sequenced. The
obtained DNA sequences were then subjected to a
BLAST search in the GeneBank™ database.
To verify the expression of the prey protein identified
in positive clones, yeast protein extracts were prepared
and analyzed by western blot. Preparation of protein
samples was performed according to the Yeast Protocol
Handbook from BD Biosciences. In brief, yeast cultures
were grown for 2 days, harvested by centrifugation, and
frozen at -80°C. The frozen cell pellets were lysed by
ressupending in the same volume of warm (60°C) crack-
ing buffer [8 M urea, 5% SDS, 40 mM Tris-HCl pH 6.8,
0.1 mM EDTA, 1% b-mercaptoethanol, 0.4 mg/mL bro-
mophenol blue] and glass beads (425-600 μm, acid-
washed, Sigma-Aldrich). The mixture was incubated at
70°C for 10 min and then vortexed for 1 min at high
speed. The lysates were then cleared by centrifugation
for 5 min at 14,000 rpm, and the supernatants were
boiled at 100°C for 5 min. Finally, western blot analysis
was performed as described below.
To confirm the detected interactions and to map the
S-HDAg domains involved in the interaction with
hnRNPC, yeast co-transformation assays were per-
formed. Yeast strain AH109 was co-transformed with
plasmids encoding S-HDAg deletion mutants and the
prey plasmid. Growth was assayed on high stringency
medium (SD/-Trp/-Leu/-Hist/-Ade/X-a-gal) to evaluate
the activation reporter genes.
Purification of recombinant proteins
Plasmids pGEX-6P-2/S-HDAg and pET28c/hnRNPC
were used to transform E. coli BL21 and BL21-
CodonPlus-(DE3)-RP competent cells, respectively.
Expression of GST/S-HDAg and His/hnRNPC proteins
was induced with 1 mM isopropyl-b-D-thiogalactopyra-
noside (IPTG) for 2 h. After centrifugation, bacterial
cells were ressuspended in PBS containing 0.1 mg/mL
lysozyme. Three freeze-thaw cycles were performed and
then the samples were treated with DNAse I (Roche).
Purification of S-HDAg from whole bacterial protein
samples was performed using a GSTrap FF 1 mL col-
umn (GE Healthcare), according to the manufacturer’s
instructions. Briefly extracts were loaded onto a column
and extensively washed. PreScission protease (GE
Healthcare) was then added to remove the GST-tag
from GST/S-HDAg. The eluted fraction containg S-
HDAg protein was dialyzed against PBS and quantified
using a Bradford assay based kit (BioRad).
Blot overlay assay
The blot overlay analysis was performed as previously
described [21] using bacterial extracts containing the
His6/hnRNPC recombinant protein. Increasing amounts
of these extracts were separated by SDS-PAGE on a
12% gel, and transferred to a nitrocellulose membrane.
The membrane was blocked with PBS containing 5%
low fat milk powder and subsequently probed with 40
μg of purified recombinant S-HDAg protein in the same
buffer, for 1 h at room temperature. After washing,
bound S-HDAg was detected by immunoblot using a
rabbit polyclonal anti-HDAg antibody (B3) [22], as
described below.
Cell culture
The human hepatocellular carcinoma cell line Huh7
(European Collection of Cell Cultures n° 01042712) and
the HDV cDNA stably transfected Huh7-D12 cell line
(Japanese Collection of Research Bioresources JCRB
0403) were used in this study. The Huh7-D12 cell line
was obtained by stable transfection of Huh7 cells with a
plasmid containing a trimer of full-length genomic HDV
cDNA. The cDNA was initially obtained from a wood-
chuck liver infected with human serum containing
HDV. Huh7-D12 cells constitutively express HDV ribo-
nucleoproteins in a pattern consistent with ongoing
HDV replication [23,24].
Both cell lines were cultured as monolayers in RPMI
1640 medium (Sigma) supplemented with 10% fetal
bovine serum (Invitrogen) and grown at 37°C in a humi-
dified atmosphere containing 5% CO2.
Co-immunoprecipitation
For co-immunoprecipitation, protein extracts from
Huh7-D12 or Huh7 cells were prepared. Cells were first
sedimented by centrifugation and resuspended in lysis
buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1%
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complete protease inhibitor cocktail (Roche). After pre-
clearing with protein G Dynabeads (Invitrogen), extracts
were incubated with a rabbit polyclonal antibody anti-
HDAg, at 4°C for 2 h. The resulting immunocomplexes
were precipitated with Protein G Dynabeads (Invitro-
gen), extensively washed with PBS, and analyzed by wes-
tern blot.
Western blot
Western blot analysis was performed essentially as pre-
viously described [23]. Protein samples were separated
on 12% SDS-PAGE gels and transferred to nitrocellulose
membranes (Schleicher & Schuell). The membranes
were blocked with PBS containing 5% low fat milk pow-
der and probed with specific primary antibodies, fol-
lowed by incubation with appropriate secondary
antibodies conjugated with horseradish peroxidase
(BioRad). Blots were developed with an enhanced che-
miluminescence system (ECL, GE Healthcare). When
needed, the density of the protein bands was determined
using the NIH ImageJ software http://rsbweb.nih.gov/ij/.
The following primary antibodies were used: mouse
monoclonal antibody against hnRNPC (Santa Cruz Bio-
technology), rabbit polyclonal anti-HDAg antibody,
mouse anti-His-tag monoclonal antibody (Sigma-
Aldrich), and rabbit polyclonal anti-clathrin antibody
(Santa Cruz Biotechnology).
Immunofluorescence and in situ hybridization
Immunofluorescence and in situ hybridization were per-
formed on Huh7-D12 cells, as earlier described [23].
For immunofluorescence cells, grown on coverslips,
were fixed with 3.7% formaldehyde and then permeabi-
lized with 0.5% Triton-X100. Cells were then sequen-
tially incubated with primary antibodies (rabbit
polyclonal anti-HDAg and mouse monoclonal anti-
hnRNPC) for 1 h at room temperature, followed by
incubation with appropriate secondary antibodies conju-
gated either with FITC or Texas Red (Jackson Immu-
noResearch Laboratories). After washing, the coverslips
were mounted in Vectashield (Vector Laboratories).
For fluorescence in situ hybridization a digoxigenin-
11-dUTP-labelled probe was used. This probe was pre-
pared by nick-translation of plasmid pSVL(D3) [19] as
previously described [24]. This plasmid contains a tri-
mer of full-length genomic HDV cDNA cloned in pSVL
(GE Healthcare). Cells, grown on coverslips, were fixed
with 3.7% formaldehyde, permeabilized with 0.5% Tri-
ton-X100, and treated with 200 U/ml RNase free DNase
I (Roche) as earlier described [24]. Cells were then
sequentially incubated with 70% formamide and 50%
formamide at 73°C, for 3 min. Hybridization was carried
out overnight at 37°C and the digoxigenin-labeled probe
was detected after incubation with a monoclonal
anti-digoxigenin antibody conjugated with FITC (Roche)
followed by incubation with a secondary anti-FITC anti-
body conjugated with Alexa-488 (Jackson Immuno-
Research Laboratories).
Confocal microscopy and image analysis
Fluorescent labeled samples were analyzed under a Zeiss
LSM 510 META confocal microscope. Green fluores-
cence was detected using a 488-nm Argon laser and red
fluorescence was detected using a 543-nm HeNe laser.
The equipment was calibrated with multicolor fluores-
cent beads (Molecular probes, USA) and a dual-band fil-
ter allowing simultaneous visualization of green and red
fluorescence.
Co-localization coefficients were calculated using Ima-
geJ software and the JACoP plugin [25]. The Manders’
overlap coefficient (OC) was calculated in order to eval-
uate co-localization between pairs of images in the red
and green channels. The values of Mander’s coefficients
range from 0 to 1, with 1 indicating 100% co-localiza-
tion and 0 indicating no co-localization [26].
siRNA knockdown assays
The knockdown of endogenous hnRNPC in Huh7 cells
was performed using a short hairpin RNA (shRNA)
strategy.
To construct shRNA-expressing vectors, oligonucleo-
tides targeting the human hnRNPC mRNA and the cor-
responding complementary sequences, were inserted
into the pSIREN-RetroQ vector (BD Biosciences). The
oligonucleotide sequences were designed according to
the guidelines provided in http://bioinfo.clontech.com/
rnaidesigner, and were as follows: 5’gatccgcagtagagatgaa-
gaatgttcaagagacattcttcatctctactgcttttttacgcgtg 3’ (sense)
and 5’aattcacgagtaaaaaagcagtagagatgaagaatgtctcttgaa-
cattcttcatctctactgcg 3’ (antisense). The underlined
sequences denote the hnRNPC shRNA sequence target-
ing the hnRNPC mRNA (nucleotides 673 to 691). The
oligonucleotides were annealed in vitro and subcloned
into the BamH Ia n dEcoR I sites, downstream of the
human U6 promotor thus yielding the pSIREN-RetroQ/
hnRNPC vector. A control vector was also generated by
using the negative control siRNA oligonucleotide target-
ing the luciferase mRNA supplied by the manufacturer
(pSIREN-RetroQ/Luc).
Transfection procedures were performed using the
FuGENE6 transfection reagent (Roche), according to the
manufacturer’s instructions. Initially, Huh7 cells were
transfected with 1 μg pSVL(D3). After 48 h incubation
cells were transfected again with pSIREN-RetroQ/
hnRNPC or pSIREN-RetroQ/Luc. 24 h post-transfection,
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mL. Finally, cells were harvested and analyzed by wes-
tern blot as described above.
Results
Identification of S-HDAg interacting proteins in a yeast
two hybrid screening
In order to identify proteins interacting with S-HDAg, a
yeast two hybrid screening was performed. The entire S-
HDAg cDNA was fused in-frame to the Gal4 DNA
binding domain and the resulting construct was trans-
formed into the yeast strain AH109. Using this bait, we
screened approximately 10
8 clones from a human liver
cDNA library, previously pre-transformed into the yeast
strain Y189. Yeast colonies were first selected on med-
ium lacking leucine, tryptophan, histidine and adenine
and subsequently assayed for a-galactosidase activity.
Plasmids were isolated from 112 positive clones and res-
cued by transformation into E. coli. The identity of the
obtained plasmids was established by sequencing allow-
ing the identification of 30 known proteins in the Gen-
Bank database (Table 2). These proteins were found to
be involved in different metabolic pathways and func-
tions, namely cell communication and signal transduc-
tion, transport, protein metabolism, immune response,
and regulation of nucleic acid metabolism (Figure 1). In
a previous study aimed to detect S-HDAg interactors,
Cao et al. [8] used a combined immunoprecipitation
Table 2 Proteins that interact with S-HDAg in the yeast two-hybrid screening
Protein Number of
clones
Biological function
Heterogeneous nuclear ribonucleoprotein C isoform 1 (HNRNPC) [NP_004491.2] 5
Raly RNA binding protein-like (RALY) [NP_057951.1] 1
Chromodomain helicase DNA binding protein 7 (CHD7) [NP_060250.2] 1
ELAV-like protein 1 (ELAVL1) [NP_001410.2] 1
Heterogeneous nuclear ribonucleoprotein A/B (HNRNPAB) [NP_112556.2] 1 Regulation of nucleic acid
metabolism
Ankyrin repeat domain 11 (ANKRD11) [NP_037407.4] 1
SWI/SNF related. matrix associated actin dependent regulator of chromatin subfamily a member 2
(SMARCA2) [NP_003061.3]
1
Zinc finger proteín 533 (ZNF533) isoform 2 [NP_001106868.1] 1
Ribosomal protein S15 (RPS15) [NP_001009.1] 1
TRAF and TNF receptor associated protein [EAW55458.1] 1 Cell communication, signal
transduction
Ribosome receptor P180 [BAF73807.1] 1
EBNA1 binding protein 2 (EBP2) [NP_006815.2] 1 Unknown
Ribosomal L1 domain containing 1 (RSL1D1) [CAA07491.1] 1
Apolipoprotein E (APOE) [NP_000032.1] 5 Transport
Proteasome activator complex subunit 2 (PSME2) [NP_002809.2] 1
BRCA1 associated protein (BAP1) [NP_004647] 1
Antithrombin III (SERPINC1) [NP_000479.1] 1 Protein metabolism
Ribosomal protein L36A like (RPL36AL) [NP_000992.1] 1
Ribosomal protein L13 (RPL13) [NP_000968.2] 2
a-1 acid glycoprotein (ORM1) [NP_000598.2] 5
Complement component C3 (C3) [NP_000055.2] 1 Immune response
Natural killer tumor recognition sequence (NKTR) [NP_005376] 1
17b hidroxyesteroid dehydrogenase 4 (HSD17B4) [NP_000405.1] 2
17b hidroxyesteroid dehydrogenase 6 (HSD17B6) [NP_003716.2] 1
ATP synthase subunit 8 [ACQ75157.1] 2
Cytochrome oxidase subunit 3 (MT-COIII) [ACT53100.1] 1 Metabolism, energy pathways
NADH dehydrogenase subunit 2 (MT-ND2) [ACT53095.1] 1
NADH dehydrogenase subunit 4 (MT-ND4) [ACQ76111.1] 1
NADH dehydrogenase (ubiquinone) 1b subcomplex subunit 7 (NDUFB7) [NP_004137.2] 1
Cytochrome oxidase subunit 1 (MT-COI) [ACI04331.1] 1
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the identification of over 100 known proteins able to
interact with FLAG-S-HDAg. Among the identified pro-
teins three were also detected as S-HDag interactors in
this study: hnRNPC, hnRNP A/B, and the RNA binding
protein RALY. Interestingly, these proteins are involved
in the regulation of RNA metabolism and belong to the
same functional group allowing to speculate about a
possible involvement in HDV replication. Taking into
consideration that hnRNPC was previously shown to
modulate the replication of a number of RNA viruses
including HCV, VSV, and influenza A [14-17],
we decided to further explore the possible interaction
between S-HDAg and hnRNPC. Four of the prey plas-
mids from the positive clones initially obtained in the
yeast two-hybrid screening contained the entire
hnRNPC ORF sequence while a fifth plasmid expressed
a truncated form of the hnRNPC protein (GAL4AD/
hnRNPC1-108), as shown in Figure 2A.
Our first approach was designed in order to confirm
the expression of a GAL4AD/hnRNPC fusion protein by
western blot analysis. Yeast protein extracts from a posi-
tive clone were prepared and the presence of protein
GAL4AD/hnRNPC1-108 (37 KDa) was investigated using
an antibody specific for hnRNPC protein. As shown in
Figure 2B, a band of the expected molecular weight
could be detected in the positive clone extracts but not
in yeast AH109 extracts (negative control), confirming
the expression of GAL4AD/hnRNPC1-108 protein.
hnRNPC and S-HDAg interact in vitro and in vivo
Having established that S-HDAg and hnRNPC interact
in the yeast two-hybrid assay, we decided to investigate
if the two proteins also interact in vitro and in vivo in
human hepatoma cells. To test for possible in vitro
interactions we performed a blot overlay assay. To do
this, both S-HDAg and hnRNPC were expressed in E.
coli, as GST or His-tag fusion proteins, respectively.
Increasing amounts of E. coli protein samples containing
His6/hnRNPC were then separated by electrophoresis,
and transferred to a nitrocellulose membrane. The
Figure 1 S-HDAg interacting partners in a yeast two-hybrid
screen. The identified proteins were grouped according to their
respective biological functions using the human protein reference
database http://www.hprd.org/.
Figure 2 Identification of hnRNPC as an S-HDAg interactor in a
yeast two hybrid screening. (A) Schematic representation of
hnRNPC and the GAL4AD fusion proteins identified in yeast positive
clones (GAL4AD/hnRNPC and GAL4AD/hnRNPC1-108). GAL4AD/
hnRNPC and GAL4AD/hnRNPC1-108 were identified in four and one
positive clones, respectively. GAL4AD/hnRNPC1-108 codes for a
truncated form of hnRNPC, that contains only the first 108
aminoacids. Both proteins contain a 5’untranslated region of
hnRNPC mRNA (black bar). GAL4AD represents the activation
domain of the GAL4 transcription factor and RRM and CC represent
the RNA recognition or coiled-coil motifs, respectively, present in
hnRNPC. (B) Western blot analysis of hnRNPC expression in yeast
positive clones. Yeast extracts were prepared, separated on 12%
SDS/PAGE gels, and immunoblotted with an anti-hnRNPC antibody.
The positive clone expressing GAL4AD/hnRNPC1-108 was used in this
analysis and AH109 yeast extracts were used as negative control.
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and the bound protein was detected with a rabbit anti-
S-HDAg antibody. The obtained results are displayed on
Figure 3A, and show that increasing amounts of His6-
hnRNPC correspond to a proportional increase in the
amounts of bound S-HDAg, suggesting a specific inter-
action between the two proteins.
Having established that S-HDAg and hnRNPC interact
in vitro, we next decided to investigate if both proteins
also interact in vivo in the human hepatoma cell line
Huh7-D12 which is stably transfected with HDV cDNA
and constitutively expresses virus RNAs and antigens.
This was performed using co-immunoprecipitation
assays using lysates from either Huh7-D12 or the paren-
tal, non-transfected Huh7 cell lines. A rabbit polyclonal
anti-HDAg antibody was used in the assays and inter-
acting proteins were detected by western blot analysis
with a mouse monoclonal antibody against hnRNPC. As
negative controls we used both Huh7-D12 lysates in the
absence of antibody and Huh7 lysates immunoprecipi-
tated with anti-HDAg antibody. As shown in the Figure
3B, hnRNPC and HDAg can be co-immunoprecipitated
in Huh7-D12 cells, but not in the negative controls, pro-
viding evidence that the two proteins are probably pre-
s e n ti nt h es a m ec o m p l e x .I ti st h u sp o s s i b l et h a tt h e
two proteins also interact in vivo in human liver cells.
195 1 NLS OLIG RNA-BD
S-HDAg
S-HDAg(1-62)
S-HDAg(63-97)
S-HDAg(98-195)
A.
B.
13
2
4
5
6
1- pAS2-1/S-HDAg + pGADT7-Rec/hnRNPC1-108
2- pAS2-1/S-HDAg 
3-pGADT7-Rec/hnRNPC1-108
4- pAS2-1/S-HDAg (1-62) + pGADT7-Rec/hnRNPC1-108
5- pAS2-1/S-HDAg (63-97) + pGADT7-Rec/hnRNPC1-108
6- pAS2-1/S-HDAg  (98-195)+ pGADT7-Rec/hnRNPC1-108
SD/-Leu SD/-Trp SD/-Leu/-Trp SD/-Leu/-Trp/-
Hist/-Ade/X-α-Gal
Figure 3 In vitro and in vivo interaction between hnRNPC and S-HDAg. (A) Overlay of bacterially expressed His6/hnRNPC with recombinant
S-HDAg. E. coli protein extracts were prepared after induction of recombinant protein expression with IPTG. Increasing amounts of His6/hnRNPC-
containing extracts (lanes 2 to 6), were separated by SDS/PAGE, blotted onto nitrocellulose membranes and overlaid with the same amount of
purified recombinant S-HDAg. Detection of S-HDAg was performed with a specific rabbit polyclonal antibody. E. coli protein extracts lacking
His6/hnRNPC (lane 1) were used as a negative control (upper panel). The presence of His6/hnRNPC in the extracts was confirmed using a mouse
anti-His-tag monoclonal antibody (middle panel). In the lower panel, the assay was performed in the absence of purified S-HDAg showing that
the anti-HDAg polyclonal antibody does not recognize hnRNPC. (B) Co-immunoprecipitation of hnRNPC with S-HDAg. Huh7-D12 cell lysates
were immunoprecipitated with an anti-HDAg antibody bound to protein G beads. The immunoprecipitates were separated on 12% SDS/PAGE
gels and immunoblotted with an anti-hnRNPC antibody. The negative controls were performed by incubation of Huh7-D12 lysates with beads
protein G beads and by immunoprecipitating Huh7 lysates with an anti-HDAg antibody.
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hnRNPC proteins are predominantly localized in the
nucleus and bind to nascent RNA polymerase II tran-
scripts, playing important roles in mRNA biogenesis
[27]. Since HDV viral transcription takes place in the
nucleus and the involvement of RNA polymerase II in
this process has been proposed [5], it is plausible to
consider that hnRNPC might influence HDV replication.
To learn more about the interaction between S-HDAg
and hnRNPC at the cellular level, the sub-cellular distri-
bution of the two interacting proteins was determined
by double immunofluorescence staining and confocal
microscopy. Huh7-D12 cells were dual labeled using
FITC or Texas Red-conjugated antibodies to detect
HDAg and hnRNPC respectively. The distribution of S-
HDAg is consistent with previous findings [24], showing
a nuclear localization, with preferential accumulation in
nuclear foci (Figure 4A). hnRNPC is widely distributed
throughout the nucleus and apparently overlaps with
HDAg (Figure 4B). The degree of co-localization was
quantified by determining Mander’s overlap coefficient
(OC). The mean OC (n = 10) determined for HDAg
Figure 4 Co-localization of hnRNPC with HDV antigens and RNA in human liver cells. (A-C) Double indirect immunofluorescence was used
to detect HDAg and hnRNPC proteins in cultured Huh7-D12 cells. Cells were fixed with 3.7% formaldehyde, permeabilized with 0.5% Triton X-
100, and incubated with an anti-HDAg antibody (A, green staining) and an anti-hnRNPC antibody (B, red staining). Combined in situ
hybridization and immunofluorescence was performed to detect HDV RNA and the hnRNPC protein. After fixation and permeabilization, cells
were hybridized with a digoxigenin-labeled probe to detect HDV RNA (D, green staining) and with an anti-hnRNPC antibody (E, red staining).
Overlaps of images are shown in panels C and F. (G) 10 individual cells from each experiment were analyzed using the ImageJ software and the
JaCoP plugin to determine the Mander’s overlap coefficient.
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Page 8 of 13and hnRNPC was 0.823 (Std. deviation = 0.007) which
indicate that the two proteins significantly co-localize.
Since the diffused nucleoplasmic distribution with addi-
tional accumulation in foci of HDAg, is consistent with
ongoing HDV RNA replication, the co-localization with
h n R N P Cm a yr e p r e s e n tab i o l o g i c a l l yr e l e v a n t
observation.
After obtaining evidences on HDAg and hnRNPC co-
localization in HDV expressing cells, we combined in
situ hybridization and immunofluorescence experiments
to analyze the co-localization between HDV RNAs and
hnRNPC protein. Indeed, because HDAgs and HDV
RNAs exhibit a similar sub-cellular distribution in cells
undergoing HDV replication [24] and hnRNPC is also
an RNA binding protein, it is likely that HDV RNAs
and hnRNPC cellular distributions are also related. To
exclude a possible contribution of hybridization signals
corresponding to the HDV cDNA integrated in the
chromosome, Huh7-D12 cells were treated with DNase
prior to hybridization as earlier described [24]. Figure 4
(D-F) shows examples of the obtained results and the
respective OC. The mean OC value was found to be
high (0.801; std. deviation = 0.066; n = 10), indicating
that both HDV RNAs and antigens significantly coloca-
lize with hnRNPC in human cells. The observed coloca-
lization of hnRNPC with HDV RNA and HDAgs is not
inconsistent with a possible interaction during virus
replication. However, this hypothesis, as well as an even-
tual role of the virus RNA in mediating and promoting
this process, needs to be further investigated.
Analysis of interacting domains of S-HDAg
In the yeast two-hybrid screening, we found that the N
terminal aminoacid sequence of hnRNPC (amino acids
1 to 108), which includes the RNA recognition motif,
was able to interact with the S-HDAg. In order to iden-
tify the regions of the S-HDAg required for interaction
with this region of hnRNPC, three truncated mutants of
S-HDAg were cloned fused to GAL4-BD and their inter-
action with hnRNPC1-108 was assessed using yeast two
hybrid assays. Since three functional domains were pre-
viously identified in the S-HDAg, a nuclear localization
signal (aa 66-75) [28], an oligomerization domain (aa
12-60) [29], and two bipartite RNA-binding domains (aa
97-143) [30], the three deletion constructs were gener-
ated in order to independently include one of the three
S-HDAg functional domains. Accordingly, these
constructs included the coding sequence for aminoacids
1-62, 63-97, and 98-195, respectively, in the S-HDAg
(Figure 5A).
Reporter expression was reproduced using intact S-
HDAg and hnRNPC1-108, confirming the interaction
A
D
S-HDAg
HDV RNA
B
hnRNPC
E
hnRNPC
C
Merge
F
Merge
G
Figure 5 Identification of S-HDAg domains involved in the S-HDAg/hnRNPC interaction, by yeast two-hybrid analyses. (A) Schematic
representation of the deletion constructs of S-HDAg cloned in the bait vector pAS2-1. OLIG, NLS and RNA-BD represent the oligomerization,
nuclear localization signal or RNA binding domains, respectively, identified in S-HDAg. (B) AH109 yeast cells were (co)transformed with the
indicated plasmids. Interactions were tested by growth selection on dropout media lacking the amino acids leucine or tryptophan (SD/-Leu or
SD/-Trp) to select for pGADT7/Rec or/and pAS2-1 plasmid constructs, respectively. Activation of reporter genes was tested on plates lacking
leucine, tryptophan, histidine and adenine, and containing X-a-Gal (SD/-Trp/-Leu/-Hist/-Ade/X-a-Gal).
Casaca et al. Virology Journal 2011, 8:358
http://www.virologyj.com/content/8/1/358
Page 9 of 13previously detected in the yeast two hybrid screening.
Additionally, the C-terminal deletion mutant, containing
residues 98-195, could activate the expression of repor-
ter genes. In contrast, the two remaining constructs cor-
responding to aa 1-62 and 63-97, were not able to
interact with hnRNPC1-108 and thus the activation of
reporter genes could not be detected (Figure 5B). This
result suggests that the S-HDAg C-terminal region con-
taining the RNA-binding domain mediates the interac-
tion with hnRNPC.
hnRNPC knockdown reduces the HDAg expression levels
Several members of the hnRNP family of proteins have
been recently shown to positively regulate the replica-
tion of hepatitis C and influenza A viruses [15,30].
Similarly to these two RNA viruses it would be possi-
ble that hnRNPs are also involved in the modulation
of HDV replication. We thus decided to investigate the
ability of hnRNPC to influence HDV replication, using
a shRNA-mediated knockdown technology. Plasmid
pSVL-D3, which contains three copies in tandem of
the HDV genome and was previously shown to be able
to initiate HDV replication [19], was used to trans-
fected Huh7 cells. After 48 hrs incubation, the cells
were transfected again with the pSIREN-RetroQ/
hnRNPC vector, encoding a shRNA specific for
hnRNPC, or the pSIREN-RetroQ/Luc, targeting the
luciferase protein, here used as a negative control. The
subsequent addition of puromycin allowed the selec-
tion of pSIREN-RetroQ expressing cells. The efficiency
of the pSIREN-RetroQ/hnRNPC construct in silencing
hnRNPC was analysed by western blot. Figure 6 dis-
plays the obtained results showing that in the presence
of the pSIREN-RetroQ/hnRNPC plasmid, the endogen-
ous hnRNPC levels were reduced to approximately
45% when compared with pSIREN-RetroQ/Luc trans-
fected cells. Although the obtained reduction in intra-
cellular hnRNPC levels was about 55%, we believe it
represented an acceptable compromise in order to
reduce of possible side effects in cellular metabolism.
In fact, although longer incubation times resulted in a
more marked inhibition of hnRNPC expression (up to
80%), cell viability was also dramatically reduced (often
less than 10%) limiting the significance of the obtained
results (data not shown).
After confirming that pSIREN-RetroQ/hnRNPC
transfection results in a reduction of endogenous
expression of hnRNPC, we decided to use the same
approach to investigate the influence of hnRNPC
silencing on HDAgs expression. Figure 6A shows the
results obtained after western blot analysis of the
relative expression of HDAgs in these experiments.
As can be observed, knockdown of hnRNPC resulted
in a decrease of 66% and 92% of S-HDAg and L-
HDAg expression levels, respectively, when compared
with the control pSIREN-RetroQ/Luc transfected
cells (Figure 6B). These results suggest that hnRNPC
may be involved in the modulation of HDV RNA
transcription or stabilization of HDAgs coding
mRNAs.
B.
Control siRNA
Clathrin
S-HDAg
L-HDAg
hnRNP C
A.
Figure 6 Silencing of endogenous hnRNPC reduces expression
of HDAgs. (A) Western blot analysis of Huh7 cells transfected with
plasmid pSVD3, and pSIREN-RetroQ constructs. Knockdown of the
hnRNPC protein was performed using a specific siRNA in Huh7 cells.
48 hrs after addition of puromycin, total protein extracts were
prepared, separated by SDS-PAGE, and transferred to a nitrocellulose
membrane. Blots were incubated with anti-hnRNPC, anti-clathrin or
anti-HDAg antibodies. The displayed images are representative of
three independent experiments. (B) Images were digitalized and
band intensity was determined using the ImageJ program. The
relative amounts of protein were obtained after normalization with
the housekeeping protein clathrin. Inhibition of HDAg expression is
presented as a percentage after comparison with the values
obtained with the negative control vector pSIREN-RetroQ/Luc
provided by the manufacturer.
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Despite being a small and simple virus the host factors
involved in HDV replication remain largely unknown.
Nevertheless, using different molecular biology and bio-
chemical approaches a number of host proteins that
interact with the virus RNA and antigens were already
identified [31]. In this work we made use of a yeast two-
hybrid approach to screen 10
8 clones from a human
liver cDNA library and identify possible S-HDAg inter-
acting proteins. The use of a similar approach has been
previously reported by Wang et al allowing identifying
NES1 as a L-HDAg interactor [32]. Interestingly, we
found in our system that when using L-HDAg as bait
this protein could self activate transcription of HIS3,
ADE2, and MEL-1 reporter genes (data not shown).
Accordingly, this observation did not allow us to further
use L-HDAg in the yeast two-hybrid screening. How-
ever, using S-HDAg as bait, we initially obtained 112
clones that after subsequent sequence analysis and data-
base search allowed identifying 30 known proteins
(Table 2). These proteins were reported to be involved
in different cellular processes including nucleic acid
metabolism, cell communication, transport, protein
metabolism, immune response, and energy pathways.
Two of the identified proteins were found to belong to
the hnRNP family of proteins: hnRNP A/B and
hnRNPC. These two proteins together with the RNA
binding protein RALY, also identified in this yeast two-
hybrid screen, were also previously identified by Cao et
al. [8] as S-HDAg interactors using an immunoprecipita-
tion followed by mass spectrometry approach. These
proteins are involved in the regulation of RNA metabo-
lism and may thus be involved in the modulation of
HDV RNA transcription and replication. This observa-
tion, and the fact that five of the positive clones
detected in the yeast two-hybrid screening were found
to code for hnRNPC, prompted us to further investigate
a possible functional significance of the interaction
between this protein and S-HDAg.
The family of hnRNP proteins has been associated
with various cellular functions namely mRNA biogen-
esis, transport and translation [33]. Since HDV is an
RNA virus highly dependent on host proteins, the iden-
tification of hnRNPC as an interactor for S-HDAg may
suggest a possible role for this protein in the HDV repli-
cation cycle. Thus we decided to explore this interaction
in order to elucidate its biological relevance.
Two isoforms of hnRNPC were previously identified:
the more abundant hnRNPC1, and a splicing variant
with a 13 aminoacid insertion, known as hnRNPC2 [12].
Both proteins form stable heterotetramers able to bind
to mRNA cooperatively [13]. Although the two isoforms
share most of the aminoacid sequence we were only
able to find hnRNPC1 among the putative interacting
clones in the yeast two hybrid screen. This result may
be explained by the fact that hnRNPC2 is expressed at
approximately one-third of the level of hnRNPC1 [12],
thus being less abundant in the human liver cDNA
library. However, the fact that we also identified a trun-
cated form of hnRNPC comprising the first 108 amino
acids which are common to both isoforms, may suggest
that S-HDAg shall be able to interact with hnRNPC2 as
well. A detailed analysis of the sequences obtained from
all the five prey plasmids coding for hnRNPC showed
an in-frame stop codon between the GAL4-AD and the
hnRNPC ORF. Accordingly, the GAL4AD/hnRNPC
fusion protein could only be produced through a stop
codon bypass event. However it has been proposed that
S. cerevisiae e n a b l e st h es y n t h e s i so fp o l y p e p t i d e sv i a
stop-codon readthrough [34]. Furthermore, in previous
yeast two hybrid screens this mechanism was also
observed, namely in the cDNA library screen with the
Lyssavirus phosphoprotein as bait, where the protein
dynein LC8 was identified as an interactor and the cor-
responding sequence also exhibited an in-frame stop
codon between the GAL4-AD and the dynein LC8 cod-
ing region [35].
Having identified hnRNPC as an S-HDAg interactor
in the yeast two-hybrid system, we decided to confirm
this interaction in vitro using a blot overlay assay with
purified S-HDAg and increasing amounts of bacterially
e x p r e s s e dh n R N P C .T h er e s u l t si n d i c a t e dt h a tt h e
interaction of the two proteins is specific since the
obtained band intensity was proportional to the
amount of hnRNPC present in the bacterial protein
samples. Next, we decided to investigate if S-HDAg
and hnRNPC interact in vivo in human liver cells. This
was performed using a co-immunoprecipitation assay
and a polyclonal antibody against HDAg allowing con-
firming the previously detected interaction between the
two proteins.
HDV replication occurs in the nucleus of infected liver
cells. It was previously demonstrated that both virus
RNA and antigens co-localize in the nucleus displaying
a diffuse pattern with additional accumulation in foci.
These foci, however, do not correspond to preferential
sites of RNA synthesis or processing [23]. If hnRNPC is
involved in HDV replication it can be expected to co-
localize with HDV components in the nucleus, namely
in the nucleoplasm. Immunofluoresecence and in situ
hybridization analysis of a human liver cell line that
constitutively expresses HDV RNAs and antigens,
allowed calculating the Mander’s overlap coefficient
between hnRNPC, HDV RNA, and HDAgs. The
obtained values, 0.823 for hnRNPC and HDV RNA and
0.801 for hnRNPC and HDAgs, revealed a significant
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Page 11 of 13degree of co-localization, supporting an eventual role of
hnRNPC in virus replication.
In an attempt to map the domains of the S-HDAg that
interact with hnRNPC we made three plasmid constructs
coding for aminoacids 12-60, 66-75, and 98-195. These
regions in the S-HDAg include the oligomerization
domain, the nuclear localization signal, and the RNA
binding domain, respectively. The ability to interact with
hnRNPC was tested in the yeast two-hybrid assay show-
ing that only the polypeptide comprising aminoacids 98-
195 could activate transcription of reporter genes. Since
in the yeast two-hybrid screen, we found that the N
terminal aminoacid sequence of hnRNPC (amino acids 1
to 108), which comprises the RNA recognition motif [13]
interacts with the S-HDAg it is plausible that the interac-
tion between the two proteins is mediated by their
respective RNA binding domains. However, our results
seem to indicate that the interaction between the two
proteins is not dependent on the presence of HDV RNA.
In fact, the interaction between the two proteins can be
detected in the absence of HDV RNA. Since hnRNPC is
the most abundant protein in the hnRNP complexes it
would be possible that the interaction with HDAg repre-
sents an artificial observation mediated by this abun-
dance. However, taken together, our data, including blot
overlay, coimmunoprecipitation and experiments aimed
at mapping the interaction domains, show that the two
proteins interact specifically.
hnRNPC has been shown to play important roles in the
replication cycle of several RNA viruses including influ-
enza A, hepatitis C, and polioviruses. Recently, Brunner
et al, showed that the rate of poliovirus RNA synthesis is
slower in a cell line expressing reduced levels of hnRNPC
[36]. Furthermore, knockdown of hnRNPC using
shRNAs resulted in a decrease of positive strand polio-
virus RNA accumulation [37]. In this study we reduced
hnRNPC expression using specific shRNAs and observed
a marked decrease in both S-HDAg and L-HDAg expres-
sion suggesting a possible role of this protein in HDV
mRNA synthesis, stabilization or transport. In this study
we didn’t investigate a possible direct effect of hnRNPC
knockdown on HDV genomic or antigenomic RNA accu-
mulation. Since S-HDAg promotes HDV RNA accumula-
tion and L-HDAg may act as a dominant negative
inhibitor of replication [38,39], reducing the intracellular
amounts of both delta antigens would certainly affect
virus RNA accumulation. However, this eventual effect
could be directly assigned to the reduced levels of
hnRNPC or represent a consequence of the diminished
amounts and relative imbalance of delta antigens.
Using a combined immunoprecipitation and mass
spectrometry approach hnRNPC was previously identi-
fied as one of the proteins that interact with a FLAG-
HDAg fusion protein [8]. The authors performed
shRNA experiments to knock down several of the iden-
tified proteins and determined the effect on the accumu-
lation of HDV RNA. However, hnRNPC was not among
the investigated proteins.
Conclusions
In conclusion, a yeast two-hybrid screening of a human
liver cDNA library allowed the identification of 30 S-
HDAg interacting proteins. Among the proteins
involved in nucleic acid metabolism hnRNPC was found
to bind in vitro and in vivo to S-HDAg. Although
shRNA-mediated knockdown of hnRNPC resulted in a
marked decrease of HDAg accumulation, further studies
are mandatory in order to clarify the precise role of this
protein in the HDV replication cycle.
Acknowledgements
We acknowledge Dr. José Rino and Dr. António Temudo (Institute of
Molecular Medicine, Lisbon) for help with the confocal microscope. This
work was supported by Fundação para a Ciência e Tecnologia (PTDC/SAU-
MII/098314/2008). AC is a recipient of a FCT PhD grant.
Author details
1Unidade de Microbiologia Médica, Centro de Malária e outras Doenças
Tropicais, Instituto de Higiene e Medicina Tropical, Universidade Nova de
Lisboa, Lisboa, Portugal.
2Laboratório de Transdução de Sinais, Centro de
Biologia Celular, Universidade de Aveiro, Aveiro, Portugal.
Authors’ contributions
AC carried out the experiments and helped draft the manuscript. MF
participated in the yeast two-hybrid screening, coordination of the study
and helped to draft the manuscript; ECS participated in the design and
coordination of the study. CC conceived the study, participated in its design
and coordination, and drafted the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 May 2011 Accepted: 20 July 2011 Published: 20 July 2011
References
1. Tiollais P, Pourcel C, Dejean A: The hepatitis B virus. Nature 1985,
317:489-495.
2. Sureau C, Guerra B, Lanford RE: Role of the large hepatitis B virus
envelope protein in infectivity of the hepatitis delta virion. J Virology
1993, 67:366-372.
3. Taylor JM: Structure and replication of hepatitis delta virus. RNA Curr Top
Microbiol Immunol 2006, 307:1-23.
4. Wong SK, Lazinski DW: Replicating hepatitis delta virus RNA is edited in
the nucleus by the small form of ADAR1. Proc Natl Acad Sci USA 2002,
99:15118-15123.
5. Filipovska J, Konarska MM: Specific HDV RNA-templated transcription by
pol II in vitro. RNA 2000, 6:41-544.
6. Yamaguchi Y, Filipovska J, Yano K, Furuya A, Inukai N, Narita T, Wada T,
Sugimoto S, Konarska MM, Handa H: Stimulation of RNA polymerase II
elongation by hepatitis delta antigen. Science 2001, 293:124-127.
7. Chang FL, Chen PJ, Tu SJ, Wang CJ, Chen DS: The large form of hepatitis
δ antigen is crucial for the assembly of hepatitis δ virus. Proc Natl Acad
Sci USA 1991, 88:8490-8494.
8. Cao D, Haussecker D, Huang Y, Kay MA: Combined proteomic-RNAi screen
for host factors involved in human hepatitis delta virus replication. RNA
2009, 15:1971-1979.
9. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG: hnRNP proteins and the
biogenesis of mRNA. Annu Rev Biochem 1993, 62:289-321.
Casaca et al. Virology Journal 2011, 8:358
http://www.virologyj.com/content/8/1/358
Page 12 of 1310. Nakielny S, Dreyfuss G: The hnRNPC proteins contain a nuclear retention
sequence that can override nuclear export signals. J Cell Biol 1996,
134:1365-1373.
11. Kataoka N, Yong J, Kim VN, Velazquez F, Perkinson RA, Wang F, Dreyfuss G:
Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-
binding protein that persists in the cytoplasm. Mol Cell 2000, 6:673-682.
12. Burd CG, Swanson MS, Gorlach M: Primary structures of the
heterogeneous nuclear ribonucleoprotein A2. Biochemistry 1989,
86:9788-9792.
13. McAfee JG, Shahied-Milam L, Soltaninassab SR, Lestourgeon WM: A major
determinant of hnRNPC protein binding to RNA is a novel bZIP-like RNA
binding domain. RNA 1996, 1139-1152.
14. Paek KY, Kim CS, Park SM, Kim JH, Jang SK: RNA-binding protein hnRNP D
modulates internal ribosome entry site-dependent translation of
hepatitis C virus RNA. J Virol 2008, 82:12082-12093.
15. Hwang B, Lim JH, Hahm B, Jang SK, Lee SW: hnRNP L is required for the
translation mediated by HCV IRES. Biochem Biophys Res Commun 2009,
378:584-588.
16. Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML: hnRNP A1 interacts
with the 5’ untranslated regions of enterovirus 71 and Sindbis virus RNA
and is required for viral replication. J Virol 2009, 83:6106-6114.
17. Gupta AK, Drazba JA, Banerjee AK: Specific interaction of heterogeneous
nuclear ribonucleoprotein particle U with the leader RNA sequence of
vesicular stomatitis virus. J Virol 1998, 72:8532-8540.
18. Noisakran S, Sengsai S, Thongboonkerd V, Kanlaya R, Sinchaikul S, Chen ST,
Puttikhunt C, Kasinrerk W, Limjindaporn T, Wongwiwat W, Malasit P,
Yenchitsomanus PT: Identification of human hnRNPC1/C2 as a dengue
virus NS1-interacting protein. Biochem Biophys Res Commun 2008,
372:67-72.
19. Kuo MYP, Chao M, Taylor J: Initiation of replication of the human
hepatitis delta virus genome from cloned DNA: Role of delta antigen. J
Virol 1989, 63:1945-1950.
20. Cunha C, Silva MC, David E, Monjardino J, Carmo-Fonseca M: Hepatitis
delta virus ribonucleoproteins shuttle between the nucleus and the
cytoplasm. RNA 2002, 8:637-646.
21. Browne GJ, Fardilha M, Oxnham SK, Wu W, Helps NR, da Cruze Silva OA,
Cohen PT, da Cruze Silva EF: Sarp, a new alternatively spliced protein
phosphatase 1 and DNA interacting protein. Biochem J 2007, 402:187-96.
22. Saldanha J, Homer E, Goldin P, Monjardino J: Cloning and expression of
an immunodominant region of the hepatitis delta antigen. J Gen Virol
1990, 71:471-475.
23. Cheng D, Yang A, Thomas H, Monjardino J: Characterization of stable
hepatitis delta-expressing cell lines: Effect of HDAg on cell growth. Prog
Clin Biol Res 1993, 382:149-153.
24. Cunha C, Monjardino J, Chang D, Krause S, Carmo-Fonseca M: Localization
of hepatitis delta virus in the nucleus of human cells. RNA 1998, 4:680-93.
25. Bolte S, Cordeliers FP: A guided tour into subcellular co-localization
analysis in light microscopy. J Microsc 2006, 224:213-232.
26. Manders E, Stap J, Brakenhoff G, van Driel R, Aten J: Dynamics of three
dimensional replication patterns during the S-phase, analyzed by double
labeling of DNA and confocal microscopy. J Cell Science 1992,
103:321-328.
27. Dreyfuss G, Kim VN, Kataoka N: Messenger-RNA-binding proteins and the
messages they carry. Nat Rev Mol Cell Biol 2002, 3:195-205.
28. Alves C, Freitas N, Cunha C: Characterization of the nuclear localization
signal of the hepatitis delta virus antigen. Virology 2008, 370:12-21.
29. Lazinski DW, Taylor JM: Relating structure to function in the hepatitis
delta virus antigen. J Virol 1993, 67:2677-2680.
30. Lee JH, Kim SH, Pascua PN, Song MS, Baek YH, Jin X, Choi JK, Kim CJ,
Kim H, Choi YK: Direct interaction of cellular hnRNP-F and NS1 of
influenza A virus accelerates viral replication by modulation of viral
transcriptional activity and host gene expression. Virology 2010,
397:89-99.
31. Greco-Stewart VS, Pelchat M: Interaction of host Cellular proteins with
components of the Hepatitis Delta virus. Viruses 2010, 2:189-212.
32. Wang YH, Chang SC, Huang C, Li YP, Lee CH, Chang MF: Novel nuclear
export signal-interacting protein, NESI, critical for the assembly of
hepatitis delta virus. J Virol 2005, 79:8113-8120.
33. Krecic AM, Swanson MS: hnRNPComplexes: composition, structure and
function. Cur Opin Cell Biol 1999, 11:363-371.
34. von der Haar T, Tuite MF: Regulated translational bypass of stop codons
in yeast. Trends in Microbiol 2007, 15:78-86.
35. Jacob Y, Badrane H, Ceccaldi PE, Tordo N: Cytoplasmic Dynein LC8
Interacts with Lyssavirus Phosphoprotein. J Virol 2000, 74:10217-10222.
36. Brunner JE, Ertel KJ, Rozovics JM, Semler BL: Delayed kinetics of poliovirus
RNA synthesis in a human cell line with reduced levels of hnRNPC
proteins. Virology 2010, 400:240-247.
37. Ertel KJ, Brunner JO, Semler BL: Mechanistic consequences of hnRNPC
binding to both RNA termini of poliovirus negative-strand RNA
intermediates. J Virol 2010, 84:4229-4242.
38. Chao M, Hsieh S-Y, Taylor J: Role of two forms of the hepatitis delta virus
antigen: evidence for a mechanism of self-limiting genome replication. J
Virol 1990, 64:5066-5069.
39. Sato S, Cornillez-Ty C, Lazinski DW: By inhibiting replication, the large
hepatitis delta antigen can indirectly regulate amber/W editing and its
own expression. J Virol 2004, 78:8120-8134.
doi:10.1186/1743-422X-8-358
Cite this article as: Casaca et al.: The heterogeneous ribonuclear protein
C interacts with the hepatitis delta virus small antigen. Virology Journal
2011 8:358.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Casaca et al. Virology Journal 2011, 8:358
http://www.virologyj.com/content/8/1/358
Page 13 of 13